لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Mizugaki, Hidenori, Yamamoto, Noboru, Nokihara, Hiroshi, Fujiwara, Yutaka, Horinouchi, Hidehito, Kanda, Shintaro, Kitazono, Satoru, Yagishita, Shigehiro, Xiong, Hao, Qian, Jane, Hashiba, Hideyuki, Shepherd, Stacie P., Giranda, Vincent, Tamura, Tomohide

المصدر: Cancer Chemotherapy and Pharmacology. November 2015 76(5):1063-1072

المصدر: Biomolecules. 11(8)

مصطلحات موضوعية: REPAIR, PTEN, MUTANT-CELLS, VELIPARIB ABT-888, glioblastoma, OLAPARIB, TEMOZOLOMIDE, DNA-DAMAGE RESPONSE, TUMORS, CANCER, PARP, BRCAness, SURVIVAL, PARP inhibitors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___01423::68ab137d4a42a3265bf002c81e00cbd2
https://research.rug.nl/en/publications/19019ac8-b570-49b4-9aac-6c318a149f4d

المؤلفون: Fernando Rezende, Bart Cornelissen, Ricardo Titze-de-Almeida, Mary-Ann E. Xavier

المصدر: Repositório Institucional da UnB
Universidade de Brasília (UnB)
instacron:UNB
Biomolecules, Vol 11, Iss 1188, p 1188 (2021)
Biomolecules

مصطلحات موضوعية: PTEN, IDH1, Estrogen receptor, DNA-DAMAGE RESPONSE, Review, Poly(ADP-ribose) Polymerase Inhibitors, Glioblastoma multiforme, Biochemistry, Proto-Oncogene Mas, Microbiology, PARP, Breast cancer, Pancreatic cancer, Biomarkers, Tumor, BRCAness, Medicine, Humans, Epidermal growth factor receptor, Molecular Biology, PARP inhibitors, BRCA2 Protein, REPAIR, biology, MUTANT-CELLS, business.industry, BRCA1 Protein, VELIPARIB ABT-888, glioblastoma, OLAPARIB, Cancer, TEMOZOLOMIDE, medicine.disease, TUMORS, CANCER, QR1-502, Proteínas, Cancer research, biology.protein, SURVIVAL, Biomarker (medicine), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d10943275facadca0bc089c76a5336b
https://repositorio.unb.br/handle/10482/43377

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Nicholas Pavlidis, Peeter Karihtala, Mehmet Akif Ozturk, Afroditi Karathanasi, Stergios Boussios, Matin Sheriff, Eleftherios P. Samartzis, Elie El Rassy, George Pappas-Gogos, Mario Uccello, Michail Tringos, Michele Moschetta

المساهمون: University of Zurich, Department of Oncology, HUS Comprehensive Cancer Center, University of Helsinki, Helsinki University Hospital Area

المصدر: Ann Transl Med

مصطلحات موضوعية: 0301 basic medicine, EPITHELIAL OVARIAN, Veliparib, endocrine system diseases, Poly ADP ribose polymerase, 3122 Cancers, 610 Medicine & health, Synthetic lethality, talazoparib, Olaparib, homologous recombination (HR), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research, ADVANCED SOLID MALIGNANCIES, Ovarian cancer, ABDOMINAL RADIATION-THERAPY, Medicine, Talazoparib, DOSE-ESCALATION, breast cancer gene (BRCA), Rucaparib, veliparib, business.industry, PRIMARY PERITONEAL, JAPANESE PATIENTS, VELIPARIB ABT-888, General Medicine, medicine.disease, 10174 Clinic for Gynecology, 3. Good health, FALLOPIAN-TUBE, 030104 developmental biology, PHASE-I, ovarian cancer, chemistry, 030220 oncology & carcinogenesis, OLAPARIB MAINTENANCE THERAPY, Cancer research, business, poly(ADP-ribose) polymerase inhibitors (PARP inhibitors)

وصف الملف: atm-08-24-1706.pdf - application/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f330a1de401262e47cd0c8efd4ee00
https://www.zora.uzh.ch/id/eprint/199041/

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.